Standard Operating Procedure (SOP) Research and Development Office
|
|
- Heather Johns
- 5 years ago
- Views:
Transcription
1 Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August 2013 Author: Approved by: Alison Murphy, Research Manager Endorsed by Paul Carlin Dr David Hill Signed: Date: 01 August 2013
2 Version History: Version No. Date Author Reason for Change 1.0 Oct 2007 Katrina Hughes N/A 2.0 Aug 2011 Alison Murphy Updated to reflect new SOP layout. Revised title. Method of selecting projects included. Audit process and template updated. Document Number: SOP/RAD/SEHSCT/006 Page 2 of 23
3 Table of contents 1. Introduction 2. Objective 3. Scope 4. Procedure 4.1 Selecting Projects for Routine Audit 4.2 Initiating the Audit 4.3 Conducting the Audit 4.4 Writing the Audit Report 5. Regulations, Guidelines, references, SOP Links etc 6. Appendices 6.1 Audit Proforma Document Number: SOP/RAD/SEHSCT/006 Page 3 of 23
4 1. INTRODUCTION An audit is: a systematic and independent examination of trial related activities and documents to determine whether the evaluated trial related activities were conducted, and the data were recorded, analysed and accurately reported according to the protocol, sponsor s Standard Operating Procedures (SOPs), Good Clinical Practice (GCP) and the applicable regulatory requirements. (ICH GCP 1.6) Audit of research within the Trust is an important function of research governance. It enables the Research Office to assess the conduct of research in the Trust, and to identify potential and actual problems and address the training needs of research staff. Throughout the audit, general information exchange between the auditor and the institution being audited is acceptable and essentially is used as an evaluation tool. This ensures that research conducted within the Trust continues to be of a high standard and we continue to provide a supportive and proactive service to Trust research staff. It also ensures that the safety of our patients and service users is maintained. An audit is an informal planned process and can take place prior to, during or after the patient recruitment phase. An internal audit is often undertaken prior to an external inspection. There are two types of Audit; Routine Random Active Project Audit and For Cause Audit. This SOP covers Routine Random Active Project Audit, There is a separate SOP for For Cause Audit (SOP 14) 2. OBJECTIVE This SOP describes the Routine Random Active Project Audit procedures of South Eastern Health and Social Care Trust Research Office (SEHSCT). This SOP specifically describes the processes for selecting those studies identified as requiring a routine random project audit. This SOP also describes the requirements and timelines for investigators to respond to these types of audit reports and implement corrective actions. 3. SCOPE This SOP applies to all research projects taking place within the South Eastern Health & Social Care Trust Document Number: SOP/RAD/SEHSCT/006 Page 4 of 23
5 4. PROCEDURE 4.1 Selecting Projects for Routine Audit When a research project is being granted final permission the required audit schedule should be agreed, depending on risk. High risk projects such as clinical trials of investigational medicinal products (CTIMPs) for which the Trust is sponsor, research involving invasive techniques, etc. would normally take precedence over relatively lower risk research such as questionnaire or non invasive projects. It may be agreed that a particular project will be subject to an audit over its lifetime or other projects will just be randomly selected. 4.2 Initiating the Audit A standard letter is sent to the Chief/Principal Investigator for the trial informing them of the intention to audit the project. A blank joint audit tool should be attached for the researchers information and preparation. A follow-up phone call should be made a few days after sending the letter, to confirm receipt of letter and awareness of audit. Prior to an inspection taking place a coordinator should be appointed, for example a research registrar/research nurse to use as a point of contact as PIs/CIs often delegate audits to their staff. During the call, questions can be answered and a date arranged to conduct the audit. Suitable accommodation should be identified and booked i.e. a space to review all documents etc. 4.3 Conducting the Audit The Research Manager is ultimately responsible for conducting research governance audits. An audit proforma (see Appendix1) needs to be completed for the audit. The audit will normally take place in the department where the research project is conducted. A random sample of 10% of Case Reports Forms (CRFs) and medical case notes should be requested. The Master File for the project should be scrutinised. However, not all files will contain all documents. The following would usually be expected: Curricula vitae of all staff Signature sheet Adverse event log Code break procedure for randomised controlled trials Document Number: SOP/RAD/SEHSCT/006 Page 5 of 23
6 Screening log Randomisation log Copy of the protocol Delegation log ( for projects with more than 2 staff) Ethics application and opinion letter Clinical Trial Authorisation (if appropriate) Copies of all correspondence R&D approval letter Blank forms (e.g. consent forms, patient information sheets) The Research Office project file should be taken to the audit. All documents in the Master File should be compared with those in the R&D Project File to ensure that they are the same version (version numbers should be clearly marked on the documents). Any deviations from the protocol or changes should be initialled, dated and signed. All documents (screening logs, randomisation logs, etc) should be accurate, legible and timely. The ethics application in the Research Office file should be compared with the copy in the Master File to ensure they are the same version. Ethical opinion letter should be checked to see if any amendments or revisions have been recommended evidence of implementation of such amendments should be found. All CRFs should have a completed consent form. The consent form should be signed by the research subject and the person taking consent on the same date. It is not acceptable to have different dates on consent forms. All medical case notes should have copies of GP letters (if applicable) informing them of the subjects participation in the research. The number of patients recruited should be assessed in relation to the length of time the project has been active and the overall predicted recruitment. Projects with a low recruitment rate or high drop out rate should be noted. All medical case notes should have Research stickers on the inside cover. Patient information sheets should also be checked to ensure the version number is the same as the version submitted for ethical approval. Consent forms and patient information literature should be printed on Trust headed paper. Check that that this done. Also check that the Trust notepaper is not out of date (i.e. it has the current Chief Executive name) All CRFs and medical case notes should be stored in locked filing cabinets in a lockable office. The storage of CRFs needs to be checked. There should be limited access to this data. Document Number: SOP/RAD/SEHSCT/006 Page 6 of 23
7 All computer based data should be password protected and there should be limited access to this data. For CTIMPS it must be ensured that all patients hospital notes are available for source documentation verification. This should include up to date annotations, GP letters, laboratory results, x-ray results etc. related to participation in the clinical trial. If there are legitimate reasons why a patient s hospital notes cannot be available, this must be explained in advance of the audit. The following personnel, where appropriate, should be available to answer questions and to attend the final meeting before the Auditor leaves the site: Chief/Principal Investigator and research personnel Personnel from other departments involved in the audit/inspection such as pharmacy, laboratory (departments should be fore-warned if the auditor /inspector intends to visit) When the auditor is satisfied that all documentation has been scrutinised and the audit form has been completed, the report should be written in the Research Office. 4.4 Writing the Audit Report The audit report should be written as soon as possible after the audit, but within two weeks from the initial audit. The following information should be included at the start of the report: Full title of the project being audited R&D reference number REC reference number Sponsor ID Chief Investigator Principal Investigator CTA Details (if applicable) An overview of the project The report should be written as follows: The detailed audit plan A review of the evidence collected Areas of good practice A discussion of any conclusions drawn from the audit A list of identified gaps in compliance An assessment of how well regulatory requirements have been met Recommendations for change in practice to confirm to regulation A date for recommended review Document Number: SOP/RAD/SEHSCT/006 Page 7 of 23
8 A copy of the finished report should be sent to the following people: Director of R&D Chief Investigator Principal Investigator If the Audit uncovers a serious breach of GCP/Protocol the Research Manager is bound by law to inform the MHRA and Main REC. The Breach must be likely to affect to a significant degree the safety or mental integrity of the subject, Trial or scientific value of the Trial. See SOP 23. A copy of the report should be maintained in the Research Office. The Chief Investigator of the study is expected to respond to the audit report within 1 month and corrective actions made within agreed timelines. If required a follow up visit can be arranged to check that the recommendations made by the audit report have been implemented. If the recommendations made by the audit report are not been implemented, it may be necessary to suspend recruitment to the research project until the recommendations are implemented. This needs to be discussed with the CI and the R&D Director. 5. REGULATIONS, GUIDELINES, REFERENCES, SOP LINKS etc. Department of Health Research Governance Framework for Health and Social Care 2 5 (2 nd Edition) UK Clinical Trials (Medicines for Human Use) regulations 2004; ICH< GCP Guidelines 2006 Linked to: SOP14 For Cause Project Audit SOP23 Notification of Serious Breaches of GCP 6. APPENDICES 6.1 Audit Proforma Document Number: SOP/RAD/SEHSCT/006 Page 8 of 23
9 Audit Proforma Routine Random Audit Site Visit date: Chief Investigator: Contact: EudraCT Number (if applicable) Purpose of audit: Routine/For Cause Study title: Project ID: R&D REC Sponsor: Study Site: Stage of Project: Initiation/During/Closure Date of Ethical Approval and the Ethics Committee approval letter: Is there a CTA? Date of CTA: If CTA is not necessary is there written evidence that this is the case? Date of R&D Final Permission at this site: 1. Approvals Ethics Yes Partial No N/A Comments Does the ethics submission match that held by the Trust R&D Office? Is there a copy of the locked ETHICS Committee application available? Is there present any correspondence with the Ethics Committee following the application, e.g. application for approval of a substantial amendment? Is there evidence of implementation of a substantial amendment, Document Number: SOP/RAD/SEHSCT/006 Page 9 of 23
10 including informing the patient or re-consenting if appropriate? Is the Site Specific Assessment documentation present and correct? Period of approval: Did the study commence within the year of Local REC Approval? What is the actual /expected end date for this study: Have annual progress/safety reports been sent to ethics? Clinical Trials Authorisation Are there copies of submission to the MHRA for a CTA? Is CTA present and correct? Have any remarks made by MHRA following CTA application been addressed? R&D Approval Is this the lead site for the study? If so are there approvals for all participating sites? Is there evidence of an appropriate identified sponsor? Is there a copy of the R&D Application? Is the Trust R&D permission letter present and correct? Has R&D been informed of the actual start date? Do R&D have contact details for the local Document Number: SOP/RAD/SEHSCT/006 Page 10 of 23
11 study co-ordinator / PI? Do all local staff involved in the study have documentary evidence of relevant training? ( i.e. GCP) Do members of the research team who are not NHS employees of this Trust have honorary contracts in place? 2. Trial Master File Trial Master File Yes Partial No N/A Comments Is there a Trial Master File available? Are the following included: A copy of the currently approved protocol, signed by the investigator ( dated prior to implementation) Previous protocol versions, signed and dated Copies of all amendments Approval of amendments by regulatory bodies (Ethics, MHRA) The Study sponsorship agreement Any other agreements where the Trust is not the Sponsor Any other financial agreements or contracts ( i.e. with a University) Insurance and Indemnity statements Copy of the Clinical Trials Agreement, signed by the relevant Document Number: SOP/RAD/SEHSCT/006 Page 11 of 23
12 personnel and all documents concerning amendments Copy of Trust R&D Approval ARSAC approval GTAC approval Copy of the Ethics application and favourable opinion letter Copy of currently approved Patient Information Sheet Copy of currently approved Consent Form ( referencing current version of Patient Information Sheet) Advertisement of subject recruitment Copy of currently approved GP letter Sample case report form Laboratory documents including ranges and laboratory accreditation Code breaking information and procedures Randomisation Log CVs of all staff: Signed and dated within the last 12 months Including GCP Relevant research training R&D Training events Research Document Number: SOP/RAD/SEHSCT/006 Page 12 of 23
13 related publications Current Investigator s brochure ( plus updates) Monitoring Log and reports Copies of yearly /interim study reports submitted to Trust R&D All critical communications, such as letters, meeting reports, notes of telephone conversations filed in a logical manner Adverse Event/ SUSAR log for the site Record of Serious Adverse Events at other sites Copies of annual and interim reports to competent authority and ethics committee, or normal Trust system Copies of annual safety reports Delegation log, including signature sheet Are all researchers on the delegation log registered with the R&D Department Completed subject participation and screening log If the main site of a Multi Centre Trial does it include: Ethical approval R&D approval Delegation logs for all sites Document Number: SOP/RAD/SEHSCT/006 Page 13 of 23
14 Will new equipment be brought in to the Trust for the purpose of the study? Will it be regularly calibrated? Insured? If applicable, electrically tested? Final report to appropriate authorities 3. Patient Information and Consent Patient Information Is the Patient Information Sheet used in the study the currently approved version (REC and R&D)? Does it match the ethics submission? Are there copies of previous Patient Information Sheets and Consent Forms as approved by the Ethics Committee? Out of hours contact information provided to patients? Does any other material given to patients have ethical approval to be used? Is Trust headed paper used? Is the Consent Form the current ethically approved version? Are all consent forms signed and dated by the subject and the Yes Partial No N/A Comments Document Number: SOP/RAD/SEHSCT/006 Page 14 of 23
15 person taking consent? Do the dates of the signatures between the patients and consent taker match? How has the patient checked (initialled or ticked) each statement? Is the Consent Form on Trust headed paper? Are all original Consent Forms, filed in recruitment order in the Site File? Is there a copy of the consent form In the CRF? In the case notes? In the master file? For the subject to keep? Are consent forms present for all those listed on the participation log? Is consent given prior to study procedures? Have any specific procedures prescribed by the protocol / ethics been adhered to? Have appropriate measures been taken for a paediatric setting? If the protocol has been amended has re-consenting been undertaken and documented appropriately? Document Number: SOP/RAD/SEHSCT/006 Page 15 of 23
16 Document Number: SOP/RAD/SEHSCT/006 Page 16 of 23
17 4. Recruitment Recruitment Yes Partial No N/A CComments How many patients to date at this Trust: Have been screened: Have been enrolled: Have been consented: Have been withdrawn: Do participants looked at meet the protocol inclusion and exclusion criteria? If not has this been correctly documented and approved? Document Number: SOP/RAD/SEHSCT/006 Page 17 of 23
18 5. Pharmacovigilance Pharmacovigilance Yes Partial No N/A Comments Is there any documented system for identifying, assessing and recording serious adverse events as required by the trials regulations, protocol and Trust? Have any SAE/SUSARs occurred in this Trial? Is there evidence that SAEs have been identified, assessed for causality, recorded and reported as required by the MHRA, REC, Sponsor and R&D in this Trust? Are reported Serious Adverse Events verifiable against patient records (i.e. adequately recorded in the source documents)? Have there been any Adverse Events that have been discovered during routine monitoring? ( this should be documented and reported to the Sponsor) Are deviations from the protocol and non compliance with legislation and guidance documented and resolved? Does the study have a data monitoring committee? Has an Annual Safety Report or end of study report been submitted to the MHRA on time? Document Number: SOP/RAD/SEHSCT/006 Page 18 of 23
19 (Number and date submitted) 6. Record Legibility Legibility Yes Partial No N/A Comments Has the investigator or person designated by the appropriate investigator made appropriate corrections, additions, or deletions that are dated and initialled by the investigator or person designated by the investigator? Do Case Report Forms and other study documents such as data collection sheets contain any entry error, omission or illegibility? Have all those that have recorded information been delegated to do so by the investigator and recorded in the delegation log? Document Number: SOP/RAD/SEHSCT/006 Page 19 of 23
20 7. Data Protection Data Protection Yes Partial No N/A Comments Is all study hard copy documentation stored in a restricted area? Is study documentation such as questionnaires and other data collection instruments designed in such a way that they do not carry patient identifiable data? Are computer records and files containing identifiable data stored on a remote and secure server? If not, why not? Is the emergency recovery procedure for retrieving data available ( e.g. Trust IT policy) Is access to electronic study records and files password protected? Are electronic data files for analysis anonymised? Are the data protection arrangements as approved by the REC? Will any documentation be archived off site? If yes, are details logged with the R&D Office? Document Number: SOP/RAD/SEHSCT/006 Page 20 of 23
21 8. Patient Health Records Patient health records Is a research consent form in the clinical notes ( signed and dated)? Does the consent form match the copy held in the CRF? Is consent entered into the electronic register? Are there consent forms relating to other concurrent research in the patient records? (If Yes, indicate which studies and date of signing) Is it stated in the patient health records that the patient has received a copy of the patient information sheet and signed consent form? Is a label attached to the health records in an appropriate place stating that the patient is taking part in a clinical trial? Is withdrawal from the study documented ( where applicable)? Are reported Serious Adverse Events verifiable against patient records? Is there present in the patient health records a letter (to GP) informing of patients trial participation? Yes Partial No N/A Comments Document Number: SOP/RAD/SEHSCT/006 Page 21 of 23
22 9. Human Tissue Act Documentation Yes Partial No N/A Comments Are samples used in this project from the : Living Deceased Are the consent forms used compliant with the HTA code of practice? Are consent forms easily accessible to those involved in the trial? If required, are Material Transfer Agreements in place containing details of: Consent procedures Tracking Use Disposal or return Are consent procedures as set out in the protocol, ethically approved and compliant with HTA codes of practice? Does each sample have a unique identifier code assigned to it? From the code and records system, I can find the following: When the body parts, tissue or cells were acquired Where from That consent was obtained Document Number: SOP/RAD/SEHSCT/006 Page 22 of 23
23 What samples have been used for If samples have been transferred to another establishment ( where and when) Are systems in place to facilitate HTA communications, NPSA alerts etc? Is there evidence of risk assessments for all practices and process involving samples? Are the premises and procedures compliant with Trust Health and Safety policies and controls? Document Number: SOP/RAD/SEHSCT/006 Page 23 of 23
Standard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationSite Closedown Checklist for UoL Sponsored CTIMP Studies
Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationStandard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:
More informationTrial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs
R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored
More informationACTIONS/PSOP/001 Version 1.0 Page 2 of 6
1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures
More informationResearch Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004
Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and
More informationSOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227
SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY SETTING FOR STAFF QUERIES Trust wide All staff involved in research Contact Jess Bisset, Research Operations Manager x20227 Guidance 1. Introduction In accordance
More informationDocument Title: Study Data SOP (CRFs and Source Data)
Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationMHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager
MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection
More informationSTANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager
STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa
More informationStandard Operating Procedure Research Governance
Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Maintaining Training Records SOP Number: 20 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date:
More informationDocument Title: Investigator Site File. Document Number: 019
Document Title: Investigator Site File Document Number: 019 Version: 1.1 Ratified by: R&D Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationSTANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice
STANDARD OPERATING PROCEDURE SOP 715 Principles of Clinical Research Laboratory Practice Version 1.2 Version date 13.11.2015 Effective date 24.04.2017 Number of pages 9 Review date June 2018 Author Role
More informationThis Agreement dated DD/MM/YYYY (the Effective Date ) is between
Clinical Trial Delegation of Sponsorship Responsibilities to Chief This Agreement dated DD/MM/YYYY (the Effective Date ) is between Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7
More informationSOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection
SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection Authorship Team: Jemma Hughes, Tina Morgan, for Joint SOP Group on Trial Processes (viz Leanne Quinn, Ian Russell, Anne
More informationStandard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research
Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationStudy Monitoring Plan Template
Study Monitoring Plan Template Sponsor Reference Number: Study Title: Principal Investigator: Study Centre: The Sponsor risk assessment form and the trial risk based monitoring strategy appendices 2 &
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationStandard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol
Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research
More informationSTANDARD OPERATING PROCEDURE SOP 325
STANDARD OPERATING PROCEDURE SOP 325 STUDY START UP ACTIVITIES FOR CLINICAL RESEARCH TRIALS Version 1.4 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 7 Review date April 2019 Author
More informationStandard Operating Procedure (SOP)
Standard Operating Procedure MANAGEMENT OF BREACHES IN RESEARCH SETTING AUDIENCE ISSUE Trustwide for research sponsored by UHBristol All research staff involved in UH Bristol sponsored research This SOP
More informationSOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup
SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup Authorship Team: Leanne Quinn for Joint SOP Group on Trial Processes (viz Ian Russell, Anne Seagrove, Jemma Hughes, Yvette
More informationMEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC
MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)
More informationInformed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019
Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number End of Study Report SOP-RES-027 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s) Natalie
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title SOP Index Number SOP 21 Version 4.0 Approval Date Effective Date Non-Compliance: Deviations and Serious Breaches of GCP and/or
More informationDocument Title: Document Number:
including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Principles of Data Collection and Storage SOP Number: 8 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationMonitoring Clinical Trials
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Urgent Safety Measures SOP-RES-022 Version Number 1 Issue Date 30 th April 2014 Effective Date 28 th May 2014 Review Date 28 th May 2016 Author(s) Reviewer(s)
More informationInvestigator Site File Standard Operating Procedure (SOP)
Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH Definition of Responsibilities for Externally
More information1. INTRODUCTION 2. SCOPE 3. PROCESS
1. INTRODUCTION This document describes the procedure for establishing and maintaining records for staff training and complies with the principles of good clinical practice (GCP) for clinical trials of
More informationQuality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D
Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017
More informationSOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School
Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head
More informationJoint R&D Support Office SOP S-2011 UHL
UNIVERSITY OF LEICESTER & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES Joint R&D Support Office SOP S-2011 UHL Site Initiation for
More informationGood Clinical Practice: A Ground Level View
Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,
More informationStandard Operating Procedure
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced
More informationSTH Researcher. Recording of research information in patient case notes
STANDARD OPERATING PROCEDURE STH Researcher Recording of research information in patient case notes SOP History None SOP Number A108 Created Research Department (AL) SUPERSEDED Final 1.3 Version 3.5 Date
More informationCorporate. Research Governance Policy. Document Control Summary
Corporate Research Governance Policy Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date:
More informationDetails: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure
Details: Author: Razwan Mahroof - QA Clinical Trials Monitor SOP Pages: 10 Version No. of replaced SOP: 1.0 Effective date of replaced SOP: 04 December 2015 Approval: Version No: of the SOP being approved.
More informationDocument Title: Informed Consent for Research Studies
Document Title: Informed Consent for Research Studies Document Number: SOP003 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationResearch & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff
Department Title of SOP Research & Development Case Report Form SOP SOP reference no: R&D GCP SOP 03 Authors: Current version number and date: J H Pacynko and J Illingworth Version 2, 01.02.18 Next review
More informationGovernance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise
Queen s University Belfast Research and Enterprise Standard Operating Procedure Research Governance Title: Delegation of Responsibilities SOP Reference QUB-ADRE-005 Date prepared 23 June 2008 Number: Version
More informationAuditing of Clinical Trials
Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1.1 Ratified by: Committee Date ratified: 23 February 2017 Name of originator/author: Rachel Fay Directorate: Medical
More informationTRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
Reference Number: UHB 317 Version Number: 1 Date of Next Review: 7th July 2019 Previous Trust/LHB Reference Number: N/A TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
More informationResearch Staff Training
REFERENCE: VERSION NUMBER: 3.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Research Infrastructure Manager REVIEWED BY: Research & Innovation Group APPROVED BY: Deputy Director of Research CONTROLLER:
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of
More informationmanaging or activities.
STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationOnce the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;
1. INTRODUCTION 2. SCOPE Feasibility assessments will ascertain any operational concerns about a research study which may delay NHS Permission or cause issues with study delivery. By conducting an assessment
More informationGCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson
GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM-005 SOP category: Trial Management Version number: 04 Version date: 10 July
More informationChecklist prior to recruiting first patient
Pre-Site selection Site Initiation Visit (SIV) What kind of questions should you ask How you should prepare for this visit Delegation logs Training logs ECRF/CRF Checklist prior to recruiting first patient
More informationSTANDARD OPERATING PROCEDURE SOP 205
STANDARD OPERATING PROCEDURE SOP 205 Adverse Events: Identifying, Recording and Reporting for CTIMPs Sponsored by the Norfolk and Norwich University Hospital NHS Foundation Trust Version 2.3 Version date
More informationMANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS DOCUMENT NO.: CR010 v4.0 AUTHOR: Heather Charles ISSUE DATE: 01 September 2016 EFFECTIVE DATE: 15 September 2016 1 INTRODUCTION 1.1 The Academic
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM 005 SOP category: Trial Management Version number: 03 Version date: 19 December
More informationGCP INSPECTION CHECKLIST
(This list is not all inclusive; item may be added &/or deleted as per the Study/Site/Sponsor/Lab) I. General. Name and address of the clinical trial site Tel. No. & e- mail:. Date of Inspection. Inspection
More informationI2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator
I2S2 TRAINING Good Clinical Practice tips Deirdre Thom Neonatal Nurse Coordinator Content Principal investigator (slides 3-5) Delegation and delegation log (slides 6-7) Informed consent (slides 8-15) Data
More informationCOMPETENCY FRAMEWORK
COMPETENCY FRAMEWORK Theresa Ledger Lead Nurse Research and Development Clinical Research Facility Sheffield C:\Documents and Settings\Robertus\My Documents\Mariann\CRF\CRF Portfolio and Competency Template_DRAFT
More informationEuropean Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS
European Medicines Agency Inspections London, 23 July 2008 EMEA/INS/GCP/197215/2005 Procedure no.: INS/GCP/3/V ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS GCP
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)
More informationResearch & Development Quality Manual
Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager Version: 3 Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School Document History
More informationMarie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance processing for the JRMO SOP Number: 26c Version Number: V1 Effective Date: 5/8/16 Review Date: 5/8/17 Author: Reviewer: Reviewer: Authorisation:
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Corrective and Preventative Action SOP-QMS-008 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s)
More informationStorage and Archiving of Research Documents SOP 6
Storage and Archiving of Research Documents SOP 6 SOP Title Storage and Archiving or Research Documents (Formerly Storage and Archiving Requirements ) SOP No. SOP 6 Author Consulted Departments Lead Manager
More informationJoint Statement on the Application of Good Clinical Practice to Training for Researchers
Joint Statement on the Application of Good Clinical Practice to Training for Researchers HRA, MHRA, Devolved Administrations for Northern Ireland, Scotland and Wales v1.1 12/10/17 Summary This joint statement
More informationDocument Title: File Notes. Document Number: 024
Document Title: File Notes Document Number: 024 Version: 1.2 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel
More informationIDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES
IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES DOCUMENT NO.: CR012 v2.0 AUTHOR: Raymond French ISSUE DATE: 18 September 2017 EFFECTIVE DATE: 02 October
More informationM. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance and Safety Reporting for Sponsored non-ctimps SOP Number: 26b Version 2.0 Number: Effective Date: 29th November 2015 Review Date: 3 rd December
More informationUnofficial copy not valid
Page 2 (9) CONTENTS 1. PURPOSE... 3 2. DEFINITIONS... 3 3. RESPONSIBILITY... 3 4. INVESTIGATOR SELECTION... 3 4.1 Identification of Investigator s... 3 4.2 Initial Contacts... 4 4.3 Distribution of Pre-Study
More informationStandard Operating Procedures
Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT
More informationVCU Clinical Research Quality Assurance Assessment
VCU Clinical Research Quality Assurance Assessment Principal Investigator Protocol Title Protocol IRB Number Name of Person Completing Assessment Date Assessment was Completed The goal of this assessment
More informationSafety Reporting in Clinical Research Policy Final Version 4.0
Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent
More informationRITAZAREM CRF Completion Guidelines
RITAZAREM CRF Completion Guidelines 10 Sept 2013 Version 1.2 Author: Michelle Lewin RITAZAREM Trial Coordinator Michelle.lewin@addenbrookes.nhs.uk Tel: +44(0) 1223 349350 Fax: +44(0) 1223 586767 Version
More informationMarie-Claire Rickard, Governance and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of or the Trial Protocol SOP Number: 037 Version Number: 5.0 Effective Date: 17/6/16 Review Date: 17/6/18 Author: Reviewer: Reviewer
More informationVersion Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13
CONTROLLED DOCUMENT Reporting Research Incidents and Breaches Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the framework and principles for reporting
More informationSOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils
Title: Assessment of Study Feasibility Manual: RI MUHC Policies and Procedures Human Research SOPs Originating Dept/ Service: RI MUHC Division of Clinical Research SOP: New Revised Reviewed Effective Date:
More informationHIC Standard Operating Procedure. For-Cause Audits of Human Research Studies
HIC Standard Operating Procedure For-Cause Audits of Human Research Studies Background As part of the Wayne State University (WSU) Human Investigation Committee s (HIC) Human Research Protection Program,
More informationThe GCP Perspective on Study Monitoring
The GCP Perspective on Study Monitoring Heidi Judge, CCRP Sr. Clinical Trials Project Manager Clinical Trials Network and Institute Massachusetts General Hospital 1 Overview Monitoring Basics Who, What,
More informationResearch Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review
Effective: 12/04/2013 Reviewed: 12/04/2015 Name of Associated Policy: Palmetto Health Administrative Research Review Definitions Responsible Positions Equipment Needed Procedure Steps, Guidelines, Rules,
More informationStandard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research
Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/006 Version V1.1 07 Apr 2016 Document Author(s) Document
More informationNN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION
NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION SOP: NN SS 401 Version No.: 2.0 Effective Date: 21Oct2016 SITE SELECTION AND QUALIFICATION Supercedes Document:
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording, Managing and Reporting Adverse Events SOP Number: 2 Version Number: 3.0 Supersedes: 2.1 Effective date: May 2013
More informationHuman Samples in Research
Human Samples in Research Adverse Event Reporting Document Identifier HTA-11-SOP-Adverse Event Reporting AUTHOR APPROVER EFFECTIVE DATE: Name and role Signature and date Name and role Signature and date
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Adverse Event Identification, Recording and Reporting in Clinical Trials of Investigational Medicinal SOP-RES-019 Version Number 2 Issue Date 08 th Dec
More informationGuidance for MRC units on HTA licence applications for storage of human samples for research purposes
Guidance for MRC units on HTA licence applications for storage of human samples for research purposes Summary In England, Wales and Northern Ireland the Human Tissue Authority (HTA) is licensing premises
More informationRD SOP12 Research Passport Honorary Contracts / Letters of Access
RD SOP12 Research Passport Honorary Contracts / Letters of Access Version Number: V2.1 Name of originator/author: Dr Andy Mee, R&I Manager Name of responsible committee: R&I Committee Name of executive
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Risk Assessment SOP-RES-002 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s)
More informationGood Documentation Practices. Human Subject Research. for
Good Documentation Practices for Human Subject Research Bridget M. Psicihulis, RHIA, CCRC Quality Improvement Unit Coordinator Human Research Protection Program Wheaton Franciscan Healthcare (last updated
More informationThe Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.
The Clinical Research Center Research Practice Manual Guideline for Study Document and Data Handling RPG-08 Purpose Guideline This Guideline provides functional definitions for common data management terms;
More information